Milestone Pharmaceuticals Announces U.S. Availability of CARDAMYST Nasal Spray for PSVT Treatment.

• CARDAMYST™ (etripamil) nasal spray is now available through U.S. retail pharmacies. • First and only FDA-approved self-administered treatment for adults with PSVT. • Conveniently available to patients through retail pharmacies. • National sales force hired with promotional launch in mid-February. • Expected $25 copay cap for eligible commercially insured patients. • Comprehensive patient assistance program offering benefits verification and reimbursement support.